MedPage Today -- An FDA-approved injected stress agent for patients who cannot exercise for myocardial perfusion imaging -- regadenoson (Lexiscan) -- appeared to be safe in patients with asthma or chronic obstructive pulmonary disease (COPD), according to results from a large randomized clinical trial.
